Atrial fibrillation in hemodialysis patients: Clinical features and associations with anticoagulant therapy

Kidney International

Volumn 77, Issue 12, 2012, Pages 1098-1106

  Wizemann, Volker ^a   Tong, Lin ^b   Satayathum, Sudtida ^b   Disney, Alex ^c   Akiba, Takashi ^d   Fissell, Rachel B ^e   Kerr, Peter G ^f   Young, Eric W ^g,h   Robinson, Bruce M ^b,g  

^a Georg Haas Dialysezentrum   (Germany)

^b ARBOR RESEARCH COLLABORATIVE FOR HEALTH   (United States)

^c QUEEN ELIZABETH HOSPITAL   (Australia)

^d TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^e LERNER RESEARCH INSTITUTE   (United States)

^f MONASH MEDICAL CENTRE   (Australia)

^g UNIVERSITY OF MICHIGAN   (United States)

^h VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

atrial fibrillation; DOPPS; outcomes; warfarin

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; WARFARIN; ANTICOAGULANT AGENT;

ADVERSE OUTCOME; AGE; ANTICOAGULANT THERAPY; COMORBIDITY; DIALYSATE; DRUG EFFICACY; DRUG SAFETY; DRUG USE; FEMALE; HEART ATRIUM FIBRILLATION; HEART VALVE PROSTHESIS; HEMODIALYSIS PATIENT; HIGH RISK PATIENT; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PATIENT IDENTIFICATION; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RACE; RANDOM SAMPLE; REVIEW; RISK ASSESSMENT; SCORING SYSTEM; VALVULAR HEART DISEASE; AGE DISTRIBUTION; AGED; ARTICLE; INFORMATION PROCESSING; KIDNEY FAILURE; MIDDLE AGED; RENAL REPLACEMENT THERAPY; STROKE; TREATMENT OUTCOME;

AGE DISTRIBUTION; AGED; ANTICOAGULANTS; ATRIAL FIBRILLATION; DATA COLLECTION; HUMANS; INCIDENCE; KIDNEY FAILURE; MIDDLE AGED; MORTALITY; PREVALENCE; RENAL DIALYSIS; STROKE; TREATMENT OUTCOME; WARFARIN;

EID: 77956897768     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2009.477     Document Type: Article

References (51)

1. Kannel WB, Abbott RD, Savage DD et al. Epidemiologic features of chronic atrial fibrillation. N Engl J Med 1982; 306: 1018-1022. (Pubitemid 12155370)
2. Feinberg WM, Blackshear JL, Laupacis A et al. Prevalence, age, distribution and gender of patients with atrial fibrillation. Analysis and implications. Arch Intern Med 1995; 155: 469-473.
3. Benjamin EJ, Wolf PA, d'Agostino RB et al. Impact of atrial fibrillation on the risk of death. The Framingham Heart Study. Circulation 1998; 98: 946-952. (Pubitemid 28446646)
4. Fustor V, Ryden LE, Asinger RW et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary. Circulation 2001; 104: 2118-2150.
5. Go AS, Hylek EM, Phillips KA et al. Prevalence of diagnosed atrial fibrillation in adults. JAMA 2001; 285: 2370-2375.
6. Go AS, Chertow GM, Fan D et al. Chronic kidney disease and the risk of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296-1305.
7. Hsu C, Vittinghoff E, Lin F et al. The incidence of end-stage renal disease is increasing faster than the prevalence of chronic renal insufficiency. Ann Intern Med 2004; 141: 95-101.
8. Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998; 32(Suppl 3): S112-S119. (Pubitemid 28527268)
9. Abbott KC, Trespalacios F, Taylor AJ et al. Atrial fibrillation in chronic dialysis patients in the United States: risk factors for hospitalization and mortality. BMC Nephrol 2003; 4: 1.
10. Ansari N, Feinfeld D, Manis T. Symptomatic atrial arrhythmias in haemodialysis patients. ASN 1997; 8: 226A/227A.
11. Estes III NA, Halperin JL, Calkins H et al. ACC/AHA/Physician Consortium 2008 Clinical performance measures for adults with nonvalvular atrial fibrillation or atrial flutter: a report of the American College of Cardiology/American Heart Association Task Force on performance measures and the physician consortium for performance. J Am Coll Cardiol 2008; 51: 865-884. (Pubitemid 351260070)
12. Fuster V, Rydén LE, Cannom DS et al. ACC/AHA/ESC 2006 Guidelines for the management of patients with atrial fibrillation: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol 2006; 48: e149-e246. (Pubitemid 44175744)
13. Gage BF, van Walraven C, Pearce L et al. Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin. Circulation 2004; 110: 2287-2292. (Pubitemid 39407328)
14. Chan KEJ, Lazarus JM, Thadhani R et al. Anticoagulant and antiplatelet usage associates with mortality among HD patients. J Am Soc Nephrol 2009; 20: 872-881.
15. Bennett WM. Should dialysis patients ever receive warfarin and for what reasons? Clin J Am Soc Nephrol 2006; 1: 1357-1359.
16. Reinecke H, Brand E, Mesters R et al. Dilemmas in the management of atrial fibrillation in chronic kidney disease. J Am Soc Nephrol 2009; 20: 705-711.
17. Wiesholzer M, Harm F, Tomasec G et al. Incidence of stroke among chronic haemodialysis patients with nonrheumatic atrial fibrillation. Am J Nephrol 2001; 21: 35-39. (Pubitemid 32238611)
18. Vasquez E, Sanchez-Perales C, Borrego F et al. Influence of atrial fibrillation on the morbido-mortality of patients on haemodialysis. Am Heart J 2000; 140: 886-890.
19. Fabbian F, Catalano C, Lambertini D et al. Clinical characteristics associated to atrial fibrillation in chronic haemodialysis patients. Clin Nephrol 2000; 54: 234-239.
20. Genovesi S, Pogliani D, Faini A et al. Prevalence of atrial fibrillation and associated factors in a population of long-term hemodialysis patients. Am J Kidney Dis 2005; 46: 897-902. (Pubitemid 41505464)
21. To AC, Yehia M, Collins JF. Atrial fibrillation in haemodialysis patients: Do the guidelines for anticoagulation apply? Nephrology (Carleton) 2007; 12: 441-447. (Pubitemid 47370950)
22. Atar I, Konas D, Acikel S et al. Frequency of atrial fibrillation and factors related to its development in dialysis patients. Int J Cardiol 2006; 106: 47-51. (Pubitemid 41728908)
23. Nakai S, Shinzato T, Sanaka T et al. An overview of dialysis treatment in Japan (as of Dec. 31, 1999). J Jpn Soc Dial Ther 2001; 34: 1121-1147.
24. Goodkin DA, Bragg-Gresham JL, Koenig KG et al. Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States in the Dialysis Outcomes and Practice Patterns Study (DOPPS). J Am Soc Nephrol 2003; 14: 3270-3277. (Pubitemid 37509303)
25. Krahn AD, Manfreda J, Tate RB et al. The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. Am J Med 1995; 98: 476-484.
26. Levin A, Thompson CR, Ethier J et al. Left ventricular mass index increase in early renal disease: impact of decline in hemoglobin. Am J Kidney Dis 1999; 34: 125-134. (Pubitemid 29318806)
27. Kramer W, Wizemann V, Thormann J et al. Cardiac dysfunction in patients on maintenance haemodialysis. Contrib Nephrol 1986; 52: 97-109.
28. Raggi P, Boulay A, Chasan-Taber S et al. Cardiac calcification in adult haemodialysis patients: a link between end-stage renal disease and cardiovascular disease? J Am Coll Cardiol 2002; 39: 695-701. (Pubitemid 34158168)
29. Schwarz K, Buzello M, Ritz E et al. Morphology of coronary atherosclerotiClesions in patients with end-stage renal failure. Nephrol Dial Transplant 2000; 15: 218-223. (Pubitemid 30064276)
30. Ribeiro S, Ramos A, Brandao A et al. Cardiac valve calcification in haemodialysis patients: role of calcium-phosphate metabolism. Nephrol Dial Transplant 1998; 13: 2037-2040. (Pubitemid 28356772)
31. Mall G, Rambausek M, Neumeister F et al. Myocardial interstitial fibrosis in experimental uremia-implications for cardiac compliance. Kidney Int 1988; 33: 804-811.
32. Amann K, Törnig J, Kugel B et al. Hyperphosphatemia aggravates cardiac fibrosis and microvascular disease in experimental uremia. Kidney Int 2003; 63: 1296-1301. (Pubitemid 36349995)
33. Varizi SM, Larson MG, Benjamin EJ et al. Echocardiographic predictors of nonrheumatic atrial fibrillation: the Framingham Heart Study. Circulation 1994; 89: 724-730. (Pubitemid 24056200)
34. Genovesi S, Vincenti A, Rossi E et al. Atrial fibrillation and morbidity and mortality in a cohort of long-term hemodialysis patients. Am J Kidney Dis 2008; 15: 255-262.
35. AFFIRM investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002; 347: 1825-1833.
36. Van Gelder IC, Hagens VE, Bosker HA et al. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med 2002; 347: 1834-1840. (Pubitemid 35417774)
37. Roy D, Talajic M, Nattel S et al. Rhythm control versus rate control for atrial fibrillation and heart failure. New Engl J Med 2008; 358: 2667-2677. (Pubitemid 351860859)
38. Singh BN, Singh SN, Reda DJ et al. Amiodarone versus sotalol for atrial fibrillation. N Eng J Med 2005; 352: 1861-1872.
39. Gersh BJ, Solomon A. Lone atrial fibrillation: epidemiology and natural history. Am Heart J 1999; 137: 592-595. (Pubitemid 29173568)
40. Krane V, Heinrich F, Meesmann M. Electrocardiography and outcome in patients with diabetes on maintenance hemodialysis. Clin J Am Soc Nephrol 2009; 4: 394-400.
41. Seliger SL, Gillen DL, Longstreth WT et al. Elevated risk of stroke among patients with end-stage renal disease. Kidney Int 2003; 64: 603-609. (Pubitemid 36871932)
42. Kawamura M, Fijimoto S, Hisanaga S et al. Incidence, outcome and risk factors of cerebrovascular events in patients undergoing maintenance haemodialysis. Am J Kidney Dis 1998; 31: 991-996. (Pubitemid 28265196)
43. US Renal Data System USRDS 2008 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD 2008.
44. Hart RG, Halperin JL. Atrial fibrillation and thromboembolism: a decade of progress in stroke prevention. Ann Intern Med 1999; 131: 688-695. (Pubitemid 29517955)
45. Zabalgoihia M, Halperin JL, Pearce LA et al. Transesophageal echocardiographic correlates of clinical risk of thromboembolism in nonvalvular atrial fibrillation. Stroke Prevention in Atrial fibrillation III investigators. J Am Coll Cardiol 1998; 31: 1622-1626. (Pubitemid 28273307)
46. Janes H, Pepe MS, Gu W. Assessing the value of risk predictions by using risk stratification tables. Ann Int Med 2008; 149: 751-760.
47. Gage BF, Waterman AD, Shannon W et al. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA 2001; 285: 2864-2870. (Pubitemid 32537350)
48. Iseki K, Kinjo K, Kimura Y et al. Evidence for high risk of cerebral hemorrhage in chronic dialysis patients. Kidney Int 1993; 44: 1086-1090. (Pubitemid 23316478)
49. Onoyama K, Kumagai H, Mishima T et al. Incidence of strokes and its prognosis in patients on maintenance haemodialysis. Jpn Heart J 1986; 27: 685-691. (Pubitemid 17212541)
50. Lo DS, Rabbat CG, Clase CM. Thromboembolism and anticoagulant management in hemodialysis patients: a practical guideto clinical management. Thromb Res 2006; 118: 385-389.
51. Young EW, Goodkin DA, Mapes DL. et al. The Dialysis Outcomes and Practice Patterns Study (DOPPS): an International Haemodialysis Study. Kidney Int 2000; 57(Suppl 74): S74-S81.